[
  {
    "trial": "PARTNER 3",
    "source_doi": "10.1056/NEJMoa2509766",
    "role": "Primary matched-curve application",
    "reason": "Specifically low-risk randomized trial; contemporary balloon-expandable platform; matched long follow-up publicly available."
  },
  {
    "trial": "Evolut Low Risk",
    "source_doi": "10.1016/j.jacc.2026.02.5063",
    "role": "Secondary graph-region application",
    "reason": "Specifically low-risk randomized trial; contemporary self-expanding platform; exact early current-lock risks not labeled, so explicit broad ranges used."
  },
  {
    "trial": "NOTION",
    "source_doi": "10.1093/eurheartj/ehae043",
    "role": "Context only",
    "reason": "Earlier CoreValve platform and older, lower-risk but not exclusively contemporary low-risk population; no substitution for the primary cohorts."
  },
  {
    "trial": "NOTION-2",
    "source_doi": "10.1161/CIRCULATIONAHA.125.076678",
    "role": "Context only",
    "reason": "Younger low-risk randomized population, but the inspected comparative follow-up is shorter than five years."
  },
  {
    "trial": "UK TAVI",
    "source_doi": "10.1001/jama.2022.5776",
    "role": "Context only",
    "reason": "Pragmatic trial not restricted to the specifically low-risk contemporary-platform population; not pooled into this application."
  }
]
